期刊文献+

原发性中枢神经系统淋巴瘤的诊治 被引量:7

The diagnosis and treatment in primary central nervous system lymphama (PCNSL)
原文传递
导出
摘要 目的探讨原发性中枢神经系统细胞瘤的临床诊断和治疗。方法回顾性分析我院2001年12月至2005年5月间经立体定向活检或手术病理证实的12例原发性中枢神经系统细胞瘤临床表现特点及治疗结果。结果12例病人中手术切除7例,立体定向活检5例。本组12例共21个肿瘤,其中7例(58.3%)为多发性肿瘤,肿瘤多位于额部、颞顶部及基底节区,11例(91.7%)病人肿瘤主体均位于小脑幕上。组织病理学检查发现12例病人均为B细胞来源。4例病人辅以放疗,8例病人辅以放疗和化疗,生存时间为4—37个月,中位生存时间为16.3个月。结论原发性中枢神经系统细胞瘤术前诊断困难,预后差,诊断主要靠病理。该疾病多采用综合治疗,术后辅以放、化疗。近年的大剂量甲氨蝶呤化疗受到关注。 Objective The purpose of our study is to explore the diagnosis and treatment in primary central nervous system lymphama. Method Twelve cases of PCNSL patients which had been defined by biopsy or surgical pathology from december 2001 to may 2005 were analyzed retrospectively. Results Seven patients were treated with surgical resection but five patients only biopsy. A total of 21 tumors were seen in 12 patients : the most commom sites were frontal, temporoparietal, and basal ganglia; multiple lesions were seen in 7 patients. In 11 of these patients,the main bulk of the tumors were in a supratentofial location. All of patients were B-cell lymphomas. The mediam follow-up was 16.3 months, ranging from 4-37 months. Conclusions PCNSL is an aggressive lymPhoma,which shows cytological variability from case to case . Accurate diagnosis before operation is difficult and the prognosis is poor. Chemotherapy combined with radiotherapy play an important role in the management of PCNSL. We need further clinical study to determine the most optimal treatment modality.
出处 《中华神经外科杂志》 CSCD 北大核心 2008年第11期808-810,共3页 Chinese Journal of Neurosurgery
关键词 中枢神经系统肿瘤 淋巴瘤 诊断 治疗 Central nervous system neoplasms Lymphama Diagnosis Therapy
  • 相关文献

参考文献11

  • 1Olsun JE,Janney CA,Rao RD,et al. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphama : a surveillance, epidemiology, and end results analysis. Cancer,2002,95 : 1504-1510.
  • 2王宏勤,范益民,毛伯镛,李丹,张尚福.原发性中枢神经系统淋巴瘤的组织病理和免疫表型研究[J].中华神经外科杂志,2004,20(4):287-287. 被引量:6
  • 3李超,孙涛,李新钢.原发性中枢神经系统淋巴瘤影像学及病理学特征[J].中华神经外科杂志,2007,23(1):46-48. 被引量:15
  • 4Hoehberg FH, Miller DC. Primaiy central nervous system lymphama. J Neurosurg, 1988,68:835-853.
  • 5Jiddane M, Nicoli F, Bergvall U, et al. Intracranial malignant lyphoma : report of 30 cases and review of the literature. J Neurosurg, 1986,65 : 592 -599.
  • 6Watanabe M,Tanaka N, Takeda N, et al. Correlation of computedtomograpby with the histophathology of primary malignant lyphoma of the brain. Neuroradiology, 1992,34 : 3642.
  • 7陈仁胜 李瑛 等.原发性中枢神经系统非何杰金氏恶性淋巴瘤[J].中华神经精神科杂志,1987,20(6):372-372.
  • 8Bataille B, Delwail V, Menet E, et al. Primary intracerebral malignant lyphoma: report of 248cases. J Neurosurg, 2000,92 : 261-266.
  • 9Poortmans PMP, Kluin-Nelemans HC, Haaxma-Reiche H, et al. High-Dose Methotrexate-based chemotherapy followed by Consolidating radiotherapy in non-AIDS-related primary central nervous system lymphama:European organization for research and treatment of cancer lymphama group phase Ⅱ trail 20962. J Clin Oncol,2003,21:4483-4488.
  • 10王建英,李发菊.大剂量甲氨蝶呤为主的联合化疗治疗原发中枢神经系统淋巴瘤[J].白血病.淋巴瘤,2006,15(1):61-62. 被引量:3

二级参考文献45

  • 1胡毅,冯奉仪,石远凯,周立强,顾大中,王奇璐.原发性中枢神经系统淋巴瘤28例临床分析[J].中华肿瘤杂志,2004,26(6):375-378. 被引量:22
  • 2刘秀芳,夏云飞,黄慧强,林旭滨,张玉晶,李勇.原发性中枢神经系统淋巴瘤的高剂量MTX化疗加放疗——附17例临床疗效分析[J].中国神经肿瘤杂志,2004,2(2):92-95. 被引量:2
  • 3李明洙,罗力,高乃康,富春雨,窦长武,王涛,李云霞.原发性颅内淋巴瘤分型及治疗[J].中华神经外科杂志,2006,22(4):259-260. 被引量:30
  • 4Ferreri A J, Reni M, Villa E. Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials.Ann Oncol, 2000, 11 (8) : 927-937.
  • 5Wu HG, Kim IH, Ha SW, et al. Survival improvement with combined radio-chemotherapy in the primary central nervous lymphomas. J Korean Med Sci, 1999, 14(5):565-570.
  • 6Hayabuchi N, Shibamoto Y, Onizuka Y. Primary central nerous system lymphoma in Japan:a nationwide survcy. Int J Radim Oncol Biol Phys. 1999,44(2) :265-272.
  • 7Corn BW, Scolt C, Donahue B, et al. Strong correlation between imaging response and survival anaong patients wilh primary central nerous system Iymphoma: a secondary analysis of RTOG studies 83-15 and 88-06. Int J Radiat Oncol Biol Phys, 2000, 47 ( 2 ) : 299-303.
  • 8Reni M, Ferreri AJ. Therapeutic management of primary CNS lymphoma in immunocompetent patients. Expert Rev Anticancer Ther,2001, 1 (3): 382-394.
  • 9Bessell EM, Lopez-Guillemao A, Villa S, et al. Importance of radiotherapy in the outcome of patients with primary, CNS lymphoma:an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments. J Clin Oncol, 2002, 20(1) :231-236.
  • 10Laperriere NJ, Wong CS, Milosevic MF, et al. Accelerated radiation therapy fcr primary lymphoma of the brain. Radiother Oncol,1998, 47(2) : 191-195.

共引文献23

同被引文献106

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部